On assessing survival benefit of immunotherapy using long-term restricted mean survival time

DOI10.1002/SIM.9662MaRDI QIDQ6617469zbMATHFDO

Authors Miki Horiguchi, Lu Tian, Hajime Uno

Publication date 11 October 2024

Published in Statistics in Medicine (Search for Journal in Brave)

zbMATH Keywords

non-proportional hazardsweighted logrank testversatile testhazard ratiodelayed difference

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites work

• scientific article; zbMATH DE number 3714717 (Why is no real title available?)
• scientific article; zbMATH DE number 49697 (Why is no real title available?)
• Checking the Cox model with cumulative sums of martingale-based residuals
• Efficiency of two sample tests via the restricted mean survival time for analyzing event time observations
• On permutation tests for comparing restricted mean survival time with small sample from randomized trials
• On the empirical choice of the time window for restricted mean survival time
• On the restricted mean survival time curve in survival analysis
• Sequential Methods for Comparing Years of Life Saved in the Two‐Sample Censored Data Problem
• Window mean survival time

This page was built for publication: On assessing survival benefit of immunotherapy using long-term restricted mean survival time

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6617469)